Browse drugs

…; P=0.012 for stroke etiology×tirofiban interaction).Conclusion Tirofiban may be associated with favorable outcomes in non-AS BAO without…

…rysm treatments may be prevented by long-term administration of tirofiban. However, due to the potential risk of complications—particular…

…ics such as recombinant tissue plasminogen activator (rtPA) and tirofiban have shown potential as adjunctive therapies. The aim of this s…

… post-procedure.Results 150 patients were included: 72 received tirofiban and 78 received dual antiplatelets. AST occurred in 2.8% of the…

…O) stroke.Aim To demonstrate the safety and efficacy of adjunct tirofiban therapy after EVT in patients with anterior circulation LVO str…

…30; P=0.172), or poor prognosis (RR, 0.981; P=0.896).Conclusion Tirofiban effectively lowers the risk of thrombosis without increasing bl…

…er and flow (CFSS >1a) showed significant improvement following tirofiban administration. Intraoperative thromboembolic complications led…

…ED removal, the ICA appeared patent but narrowed and irregular. Nimodipine (1 mg) and IV tirofiban were administered. Serial checks over a…

…iency and the requirement for Dual Antiplatelet Therapy (DAPT), aspirin was considered as a treatment option after thorough consultatio…